Literature DB >> 25406219

Steroid-induced hypocalcaemia with tetany in a patient with hypoparathyroidism.

Dimitrios Oikonomou1, Ageliki Laina1, Aikaterini Xydaki1, Constantinos Christopoulos1.   

Abstract

Although glucocorticoids have a known negative effect on calcium balance, they do not normally cause clinically significant hypocalcaemia. A young woman with post-surgical hypoparathyroidism developed symptomatic hypocalcaemia on two occasions following treatment with intravenous hydrocortisone for allergic reactions. Oral calcium and vitamin D supplementation could not prevent the development of hypocalcaemia. She was treated successfully with intravenous calcium gluconate infusions and discontinuation of glucocorticoids. In patients with hypoparathyroidism, impaired parathyroid hormone response to steroid-induced negative calcium balance may result in severe symptomatic hypocalcaemia requiring hospitalisation. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25406219      PMCID: PMC4244442          DOI: 10.1136/bcr-2014-207562

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  CORTICOSTEROID-INDUCED TETANY IN LATENT HYPOPARATHYROIDISM.

Authors:  A KAHN; I SNAPPER; A DRUCKER
Journal:  Arch Intern Med       Date:  1964-09

Review 2.  Medications that affect calcium.

Authors:  Mary D Ruppe
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

3.  Effect of glucocorticoids on function of the parathyroid glands in man.

Authors:  R F Fucik; S C Kukreja; G K Hargis; E N Bowser; W J Henderson; G A Williams
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

4.  Corticosteroids precipitating hypocalcemic encephalopathy in hypoparathyroidism.

Authors:  R Handa; J P Wali; R I Singh; P Aggarwal
Journal:  Ann Emerg Med       Date:  1995-08       Impact factor: 5.721

5.  Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy.

Authors:  Y Suzuki; Y Ichikawa; E Saito; M Homma
Journal:  Metabolism       Date:  1983-02       Impact factor: 8.694

6.  Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man.

Authors:  T J Hahn; L R Halstead; D T Baran
Journal:  J Clin Endocrinol Metab       Date:  1981-01       Impact factor: 5.958

7.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

8.  The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.

Authors:  H K Nielsen; K Thomsen; E F Eriksen; P Charles; T Storm; L Mosekilde
Journal:  Bone Miner       Date:  1988-04

9.  Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3.

Authors:  P Vardi; A Benderly; A Etzioni; J Levy; Z Hochberg
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

10.  Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy.

Authors:  Yuka Kinoshita; Kazuhiro Masuoka; Shigesaburo Miyakoshi; Shuichi Taniguchi; Yasuhiro Takeuchi
Journal:  Bone       Date:  2007-09-22       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.